Aarti Pharmalabs Ltd - 543748 - Certificate Pursuant To Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2023.
Certificate pursuant to Regulation 40(9) of the SEBI (LODR) Regulations, 2015 for the year ended March 31, 2023. Aarti Pharmalabs Ltd - 543748 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended March 31, 2023.
Compliance Certificate pursuant to Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the financial year ended March 31, 2023. Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window
Intimation of Closure of Trading Window. Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation regarding Credit rating Aarti Pharmalabs Ltd - 543748 - Financial Statements For The Nine Months Ended December 31, 2022
Financial Statements for the nine months ended December 31, 2022 Aarti Pharmalabs Ltd - 543748 - Listing of equity shares of Aarti Pharmalabs Ltd
Trading Members of the Exchange are hereby informed that effective from January 30, 2023, the equity shares of Aarti Pharmalabs Ltd (Scrip Code: 543748) are listed and admitted to dealings on the Exchange in the list of ''T'' Group Securities. For further details please refer to the notice no 20230125-6 dated January 25, 2023.